Johnson & Johnson board member Dr. Mark McClellan says the company expects 20 million doses delivered by the end of March as the U.S. becomes one step away from adding a third safe and effective … [read more]
Johnson & Johnson board member Dr. Mark McClellan says the company expects 20 million doses delivered by the end of March as the U.S. becomes one step away from adding a third safe and effective … [read more]